Mandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics
Summary by AI BETAClose X
IDEX Biometrics ASA has completed Tranche 2 of its private placement, which includes 1,642,363 shares at NOK 3.00 each, following the EGM approval on January 20, 2026. A company closely related to CEO and CFO Anders Storbråten, Pinchcliffe AS, subscribed to 616,667 shares at the same price. Following this transaction, Mr. Storbråten and his close relations now hold 12,335,515 shares, representing 18.97% of IDEX Biometrics' total outstanding shares and votes.
Reference is made to IDEX Biometrics ASA's disclosure on 4 December 2025 of a private placement of 7,333,333 shares at NOK 3.00 per share, split into two tranches.
The Tranche 2 shares were approved by the Company’s EGM on 20 January 2026. In tranche 2 of the private placement includes 1,642,363 shares.
IDEX discloses the following information on behalf of primary insider.
Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 616,667 shares at NOK 3.00 per share. After the subscription by Pinchcliffe, Mr. Storbråten and close relations hold 12,335,515 or 18,97% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 2.
Latest directors dealings
- 5 hours ago Luceco
- 5 hours ago Helios Towers
- 6 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 6 hours ago Naked Wines